Associations Between Antiretroviral Regimen and Changes in Blood Pressure: Results From the D2EFT Study
Clinical Infectious Diseases · 05.02.2025 · 80 (1) · 160-163
DOI: 10.1093/cid/ciae256 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 09.05.2024. Verfasst von Phyo Pyae Nyein und 11 weiteren Autor:innen. Beteiligte Einrichtung: The Kirby Institute, University of New South Wales, Sydney, Australia. Hauptthemen laut MEDLINE: Anti-HIV Agents, Anti-Retroviral Agents, Antiretroviral Therapy, Highly Active, Blood Pressure. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: UNITAID, National Institute of Allergy and Infectious Diseases, NIH HHS.
Abstract (Originalsprache)
In this randomized controlled study, individuals taking dolutegravir+darunavir/ritonavir had greater increases in systolic and diastolic blood pressure than those taking 2 nucleoside reverse-transcriptase inhibitors+darunavir/ritonavir at week-48. The difference remained significant after controlling for confounding factors, including weight gain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Kirby Institute, University of New South Wales, Sydney, Australia.
- University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe.
- International Research Center of Excellence (IREC), Institute of Human Virology Nigeria, Abuja, Nigeria.
- VHS Infectious Diseases Medical Centre, Chennai Antiviral Research and Treatment Clinical Research Site (CART CRS) Voluntary Health Services (VHS), Chennai, India.
- The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
- University of Malaya Medical Centre (UMMC), Kuala Lumpur, Malaysia.
Förderung
- UNITAID
- National Institute of Allergy and Infectious Diseases
- NIH HHS
- National Health and Medical Research Council, Australia
- ViiV Healthcare, and Janssen
- NIAID NIH HHS
- National Institutes of Health
Zitieren
APA
Nyein, P. P., Petoumenos, K., Borok, M., Eriobu, N., Kumarasamy, N., Avihingsanon, A., Azwa, I., Dao, S., Cisse, M., Dharan, N. J., Hanson, J., & Matthews, G. V. (2025). Associations Between Antiretroviral Regimen and Changes in Blood Pressure: Results From the D2EFT Study. Clinical Infectious Diseases, 80(1), 160-163. https://doi.org/10.1093/cid/ciae256
Vancouver
Nyein PP, Petoumenos K, Borok M, Eriobu N, Kumarasamy N, Avihingsanon A, et al. Associations Between Antiretroviral Regimen and Changes in Blood Pressure: Results From the D2EFT Study. Clinical Infectious Diseases. 2025;80(1):160-163. doi:10.1093/cid/ciae256
BibTeX
@article{Nyein2025,
author = {Nyein, Phyo Pyae and Petoumenos, Kathy and Borok, Margaret and Eriobu, Nnakelu and Kumarasamy, Nagalingeswaran and Avihingsanon, Anchalee and Azwa, Iskandar and Dao, Sounkalo and Cisse, Mohamed and Dharan, Nila J and Hanson, Josh and Matthews, Gail V},
title = {Associations Between Antiretroviral Regimen and Changes in Blood Pressure: Results From the D2EFT Study},
journal = {Clinical Infectious Diseases},
year = {2025},
volume = {80},
number = {1},
pages = {160--163},
doi = {10.1093/cid/ciae256}
}
EUVIMED